InvestorsHub Logo

XenaLives

02/22/17 7:50 PM

#92772 RE: F1ash #92767

My thoughts - it's a good thing that Anavex used multiple indicators, including quality of life, and not just the MMSE.

You're right. As a diagnostic tool it is unreliable.

.... and your point is?????

Maple tree

02/22/17 8:46 PM

#92781 RE: F1ash #92767

Good reading and education

frrol

02/23/17 8:33 AM

#92836 RE: F1ash #92767

Yes. That's why late stage clinical trials must be large and robust. Medical science is not easy and there are no short cuts, nor magic beans.